key: cord-0817396-n0qfex9g
authors: Khalifa, Shaden A.M.; Yosri, Nermeen; El-Mallah, Mohamed F.; Guo, Reem Ghonaimb Zhiming; Musharraf, Syed Ghulam; Du, Ming; Khatib, Alfi; Xiao, Jianbo; Saeed, Aamer; El-Seedi, Haged H.R.; Zhao, Chao; Efferth, Thomas; El-Seedi, Hesham R.
title: Screening for natural and derived bio-active compounds in preclinical and clinical studies: one of the frontlines of fighting the coronaviruses pandemic
date: 2020-08-29
journal: Phytomedicine
DOI: 10.1016/j.phymed.2020.153311
sha: f7a8d166836c9737279a80c96a2d61c8aa51a44e
doc_id: 817396
cord_uid: n0qfex9g

BACKGROUND: Starting December 2019, mankind faced an unprecedented enemy, the COVID-19 virus. The world convened in international efforts, experiences and technologies in order to fight the emerging pandemic. Isolation, hygiene measure, diagnosis, and treatment are the most efficient ways of prevention and intervention nowadays. The health organizations and global care systems screened the available resources and offered recommendations of approved and proposed medications. However, the search for a specific selective therapy or vaccine against COVID-19 remains a challenge. METHODS: A literature search was performed for the screening of natural and derived bio-active compounds which showed potent antiviral activity against coronaviruses using published articles, patents, clinical trials website (https://clinicaltrials.gov/) and web databases (PubMed, SCI Finder, Science Direct, and Google Scholar). RESULTS: Through the screening for natural products with antiviral activities against seven types of the human coronavirus, extracts of Lycoris radiata, Gentiana scabra, Dioscorea batatas, Cassia tora, Taxillus chinensis Cibotium barometz and Echinacea purpurea showed a promising effect against SARS-COV. Out of the listed compound Lycorine, emetine dihydrochloride hydrate, pristimerin, harmine, conessine, berbamine, 4`-hydroxychalcone, papaverine, mycophenolic acid, mycophenolate mofetil, monensin sodium, cycloheximide, oligomycin and valinomycin show potent activity against human coronaviruses. Additionally, it is worth noting that some compounds have already moved into clinical trials for their activity against COVID-19 including fingolimod, methylprednisolone, chloroquine, tetrandrine and tocilizumab. CONCLUSION: Natural compounds and their derivatives could be used for developing potent therapeutics with significant activity against SARS-COV-2, providing a promising frontline in the fighting against COVID-19.

Coronaviruses were isolated in 1965 from the respiratory tract of adult humans with common cold symptoms (Kahn and McIntosh, 2005) . At the beginning, the endemic corona viruses such as: HCoV-229E, HCoV-OC43, HCoV-NL63, and HCoV-HKU1 caused mild upper respiratory disease in humans (Chan and Chan, 2013) . In the past two decades coronaviruses have appeared on a large pandemic scale displayed by the appearance of the severe acute respiratory syndrome virus (SARS-CoV) followed by the other types of Coronaviruses (MERS-CoV) (Chan-Yeung and Xu, 2003) . The severe respiratory syndrome virus reached many countries and affected many people after crossover from animal (bats as a natural reservoir host) to human, causing high fatality rates (Yuan et al., 2017) . The novel SARS-CoV-2 belongs to the coronavirus family that appears to have originated from bats with unknown intermediate host (s) .

Nowadays, the incidence and spread of the new coronavirus disease 2019 in Wuhan City, Hubei province in China became a threat to the world and a recent public health crisis (Singhal, 2020) . On the 11 th of February 2020 the International Committee on Taxonomy of Viruses called it the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Chhikara et al., 2020) . The primary causative factor of infection transmission is the direct contact with patients such as: handshakes, contaminated surfaces and indirect inhalation of infected respiratory droplets, hence the incubation period which should be enforced around 14 days (Chhikara et al., 2020; Sohrabi et al., 2020) .

The usual clinical signs are manifested as: dry cough, fever, headache, pneumonia, and breathing difficulties (dyspnea). Subsequently, the respiratory infection causes alveolar damage and respiratory failure, additionally, a decrease in the number of white

Human coronaviruses (CoVs) are enveloped viruses, classified into seven types namely HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, SARS-CoV, MERS-CoV and SARS-CoV-2 (COVID-19) ( Fig. 1) (Corman et al., 2018; Pillaiyar et al., 2020) .

The first two CoVs were reported in 1960's, followed by the discovery of four other types in the 1970's (Lau et al., 2006) . The first four have been accompanied by symptoms such as the common cold, cough, fever, nasal congestion, sore throat, sneezing, and neurological diseases (Walsh et al., 2013; Woo et al., 2005) . Their distribution was related mainly to temperate climates during the winter and spring months but geographically they have been observed all over the world (Talbot et al., 2009) . HCoV-229E entered cells via binding to the aminopeptidase N receptor (CD13) found on the surface (Yeager et al., 1992) . The incubation period ranged between 2-5 days (Lessler et al., 2009) . The HCoV-229E virus replicated in the epithelial cell line of the trachea (Shirato et al., 2017) . The First isolation for the HCoV-NL63 type was observed in a 7-month-old baby in early 2004 (Fielding, 2011) . Different clinical evidences were reported and showed that HCoV-NL63 induced similar symptoms to those associated with HCoV-229E and HCoV-OC43 (Talbot et al., 2009) . Since HCoV-NL63 and HCoV-229E can share 65% of their amino acid identity, they have an identical mechanism of cellular entry (van der Hoek et al., 2004) .

Severe Acute Respiratory Syndrome Coronavirus (SARS CoV) disproportionately infected adults, with notable severe symptoms i.e. fever, chills, myalgia, malaise, and headache, followed by a non-productive cough and dyspnea 3-5 days later (Fowler et al., 2003; Tsui et al., 2003) . SARS-CoV was also named atypical pneumonia and was recorded as the first pandemic virus in human history (Peiris et al., 2003) . Its incubation period is 2-10 days (World Health Organization, 2003) . Young children and infants infected with SARS-CoV suffered from less severe symptoms than youth and adults (Bitnun et al., 2003) . Infection with SARS-CoV type started by the inoculation of respiratory tract mucosa through Angiotensin-converting enzyme 2 (Li et al., 2003) .

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) rarely infected children, but it can cause severe infections for youth. Infected cases with MERS-CoV suffered from many symptoms i.e. fever, cough, chills, sore throat, myalgia, arthralgia, dyspnea, pneumonia, diarrhea and vomiting (Assiri et al., 2013) . It was isolated for the first time in a Saudi Arabian patient in 2012, then in another case from South Korea in 2015. About 2500 fatality cases were reported in February 2020 (Gao et al., 2016; Hilgenfeld and Peiris, 2013; Ye et al., 2020) . Its incubation period ranged from 2-13 days (Coleman and Frieman, 2013) . MERS-CoV infection started with inoculation of the respiratory tract mucosa mediated by functional receptors such as dipeptidyl peptidase 4 (DPP4) (Ng et al., 2016) . Then the world faced a new challenge in December 2019, starting with the recording of the first SARS-CoV-2 case in Wuhan, Hubei province, China . The statistics reported on the of 14 th July 2020, confirmed that the number of fatality cases reached 570288 total cases worldwide (World Health Organization, 2020a).

SARS-CoV-2 causes severe respiratory infection accompanied by different symptoms i.e. fever, cough, dyspnea, myalgia, and headache . SARS-CoV-2 is mostly less pathogenic, but spreads more compared to SARS-CoV and MERS-CoV (Zhou et al., 2020).

In Wuhan, the capital of central China's Hubei province, the Coronavirus (COVID-

System recorded the first case on December 8, (Bai et al., 2020 Wu and McGoogan, 2020) . The city's Huanan Seafood Market was the origin of the zoonotic virus SARS-CoV-2 which was transferred rapidly (Chan et al., 2020) . The recent phylogenetic analysis detected that SARS-CoV-2 may be evolved from a strain found in bats, thus considered the natural reservoir host of SARS-CoV-2 (H. . Till now, the researchers are not sure about the intermediate host(s) of SARS-CoV-2 or whether the infection can be transmitted directly from bat to human . It was then recognized as worldwide pandemic disease that can be transmitted rapidly between humans through droplets or direct contact (Z. .

2019-nCoV (COVID-19; also named severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel member of the coronaviruses .

Nevertheless, it has a specific gene sequence that differentiates it from previously sequenced coronaviruses . Interestingly, it has an 88% shared identity with SARS-CoV and about 50% to MERS-CoV, indicating that it belongs to the same species (H. Lu et al., 2020) . The phylogenetic analysis done to classify SARS-CoV-2 revealed that it falls into the Sarbecovirus subgenus of the genus Betacoronavirus Zhu et al., 2020) .

In general, HCoVs are long and positive single stranded RNA viruses characteristic of two groups of proteins; the first group is namely the structural proteins: Spike (S), Nucleocapsid (N), Matrix (M), and Envelope (E) (Fig. 2) , while the second group is nonstructural proteins: proteases (nsp3 and nsp5) and RdRp (nsp12) (Elfiky et al., 2017) . In the case of SARS-CoV-2, the densely glycosylated spike protein found on the outer surface is arranged in this way in order to facilitate the recognition, attachment, and entry into the host cell (Ibrahim et al., 2020) . Similarly, the genetic material of SARS-CoV-2 is a positive sense RNA strand (Chhikara et al., 2020) . SARS-CoV-2 was described with a transmission electron microscope (TEM) where the double-wall surface of SARS-CoV-2 was seen, but it gives only a poor description of the different organelles in the cytoplasm (Chhikara et al., 2020; Walls et al., 2020) . Thus, it was assumed that SARS-CoV-2 has distinct ultrastructural features similar to the coronavirus family such double-membrane vesicles, large granular areas of cytoplasm and nucleocapsid inclusions, in addition to viral proteins and genetic material RNA (Chhikara et al., 2020). are similar in the mechanism of replication (He et al., 2020) . Its replication begins with the binding of its spike protein (S) into the host's cell surface molecules (Sahin et al., 2020) . Usually, (S) protein is divided functionally into the S1 domain, responsible for binding to human receptors, and the S2 domain is responsible for cell membrane fusion (He et al., 2004) . SARS-CoV-2 enters the host cells through recognition of human receptor angiotensin-converting enzyme 2 (ACE2) . RNA material of SARS-CoV-2 undergoes replication and transcription after the fusion with the plasma membrane. Replicase proteins of SARS-CoV-2 are generated from translation of positive sense RNA genomes through open reading frame 1a/b (ORF1a/b). These proteins use positive sense RNA as a template to generate full-length negative sense RNA. Then proteins are collected with new RNA genome assembly in the endoplasmic reticulum (ER) and Golgi-apparatus ( Fig. 3) (He et al., 2020) . Biophysical and structural analysis confirmed that the S protein of SARS-CoV-2 has an affinity to bind with ACE2 about 10-20 times higher than the S protein of SARS-CoV (Wrapp et al., 2020) . The high affinity of the S protein for human ACE2 can facilitate the spread of SARS-CoV-2 between humans .

The studies conducted on the COVID-19 infection mechanism showed an increase in leukocyte levels, plasma pro-inflammatory cytokines i.e. IL-6, and blood C-reactive protein values from the normal range . Lower numbers of T and B lymphocytes in peripheral blood are observed and coagulation parameters i.e. D-Dimer raise abnormally . The main pathogenesis of the COVID-19 infection is described as extreme pneumonia, RNAaemia, and acute cardiac injury . The high rate of renal failure was observed in patients with COVID-19, suggesting the development of renal dysfunction (Q. .

The human-to-human spread is now the primary way of transmission of the infection; from both symptomatic and asymptomatic individuals. The transmission from symptomatic patients occurs to nearby individuals but does not occur through air.

Transmission from asymptomatic individuals occurs through direct contact, handshaking (Kam et al., 2020) , touching contaminated surfaces (Bai et al., 2020) or droplets spread by coughing or sneezing then touching the mouth, nose or eyes (Pan et al., 2020) . Therefore, the human-to-human transmission depends on proximity and increased population density. Also, Leung et al., 2020 proved that inadequate use of masks could lead to increased chances of infection transmission On the other hand, SARS-CoV-2 has infected roughly 7690708 individuals in more than 200 countries until the 14 th of June 2020 (World Health Organization, 2020b). Meaning that the transmission of SARS-CoV-2 is higher than SARS-CoV. Li et al., 2020 proved that the high spread of COVID-19 is due to the genetic recombinant S protein (Q. . Initial reports identified two species of snakes that may be a reservoir of SARS-CoV-2 (Ji et al., 2020; Rothan and Byrareddy, 2020) . Mammals or birds are the only evidenced reservoirs of SARS-CoV-2 (Bassetti et al., 2020). Genomic sequence analysis of SARS-CoV-2 showed an 88% identity share with two bat-derived severe acute respiratory syndrome (SARS)-like coronaviruses (Chan et al., 2020; Lu et al., 2020; . Despite the fact that the genetic material of SARS-CoV-2 is compatible with other types of coronavirus, its gene sequences remarkably differ from previous sequences of other CoV types (Zhou et al., 2020) . The genetic studies of SARS-CoV-2 showed that its sequence shared 79% identity with the other CoVs types .

Despite huge efforts, the world has been unable to discover potential therapies or vaccines against COVID-19, thus most of the scientific efforts are now allocated towards trying to locate a proper medication from the old conventional drugs applied earlier for previous coronavirus varieties, among them are HCoV-229E, HCoV-OC43, HCoV-NL63, and HCoV-HKU1 which caused mild upper respiratory disease in humans, as well as severe acute respiratory syndrome (SARS)-CoV and Middle East respiratory syndrome (MERS)-CoV (Pillaiyar et al., 2020) . Natural products, mainly plants, remain as a rich source of novel therapeutic agents for the treatment of different human illnesses (Yang et al., 2020) . In this context, many natural product derivative therapeutic agents have been Glycyrrhizin (34) is an active terpenoid saponin compound isolated from liquorice roots (Glycyrrhiza glabra L.). Liquorice roots have been used in traditional medicine as prophylactic agent for gastric and duodenal ulcers, anti-inflammatory, contraceptive, laxative, anti-asthmatic, galactagogue, and antiviral, and expectorant (Damle, 2014; Sato et al., 1996) . Cinatl et al. demonstrated that glycyrrhizin inhibited SARS virus replication by inhibition of adsorption. The penetration of the virus at early steps of the replicative cycle was stopped at both concentrations of (EC 50 of 300 mg/L) and CC 50 value of >20 000 mg/L in comparison to ribavirin (positive control) when greater than >1000 that could not be tolerated by the target tissue or organs (Cinatl et al., 2003) . Toona sinensis Roem, is a Chinese traditional plant belonging to the Meliaceae family. In folk medicine, the leaves of the plant were used to treat gastric ulcers, enteritis, dysentery, cerebrovascular, and cardiovascular diseases (Kakumu et al., 2014) . TSL-1, a fraction of the aqueous extract of the plant leaves showed anti-viral activity against SARS-coronavirus with EC 50 of 30 µg/mL and CC 50 value >500 µg/mL via inhibition of the viral replication. Determination of CC 50 takes place by decreasing the cell viability by 50% (Chen et al., 2008) . Another study was conducted by Wen et al., where 200 plants were tested and only five of them, namely Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis, exerted survival inhibition of SARS-CoV (Wen et al., 2011) .

The plants possess a wide range of folk applications including liver disorder, inflammation and pneumonia treatment Oh et al., 2004; Pawar and D'mello, 2011; Zhang et al., 2013) . The potent inhibition of SARS-CoV viral enzymatic activity (SARS-CoV 3CL protease) occurred between 25-200 µg/ml and the most potent plants were C. barometz and D. batatas with IC 50 value of 39 and 44 µg/ml respectively.

The six plant extracts recorded the same CC 50 value of >500 µg/ml in comparison with valinomycin (positive control) that has value of 75.01 µg/mL. The determination of CC 50

showed that reduction of cell viability by 50% and there was no effect on the growth of host cells, indicating the effectiveness and safety of these extracts (Wen et al., 2011) . Marines natural products, i.e. halitunal (69), mycalamide (70) and esculetin-4carboxylic acid ethyl ester (68) showed antiviral activity against coronaviruses. Halitunal is a diterpene aldehyde isolated from the marine alga Halimeda tuna, known to exert an impact against murine coronavirus strain A59 at a dose of 20 µg by reduction of cell fusion (Koehn et al., 1991) . Mycalamide is an alkaloid compound isolated from the Mycale sp. sponge that inhibited the MHV-A59 coronavirus replication by blocking the protein synthesis (Donia and Hamann, 2003) . Additionally, esculetin-4-carboxylic acid ethyl ester, is a coumarin compound derived from the Axinella cf. corrugate sponge that down-regulates the SARS 3CL-protease (Lira et al., 2007) . Streptomyces cinnamonensi actinobacteria culture containing glucose, soybean oil, and grit (Łowicki and Huczyński, 2013) . Monensin sodium exhibited antiviral activity against diverse coronaviruses (EC 50 = 0.18-3.81 µM) (Shen et al., 2019) . Formerly, monensin and monensin sodium inhibited avian infectious bronchitis virus replication by blocking glycoprotein transport to plasma membranes at the level of the Golgi complex (Alonso-Caplen et al., 1984; Niemann et al., 1982) . Cycloheximide, oligomycins, valinomycin and antimycin A were used against a wide spectrum of Coronaviruses by inhibiting protein synthesis and viral replication with EC 50 of (0.43-5.21), (0.19 -6.43), (1.89-6.78) and (1.65-6.89), respectively. As well these compounds recorded CC 50 value range between (2.96-3.24), (4.26-6.78), (4.12-6.15) and (3.62-4.32) respectively (Shen et al., 2019) .

Mycophenolic acid (MPA) (75) was first isolated from Penicillium spp. fungi by Bartolomeo Gosio in 1893 and was reported to have an immunosuppressive activity against psoriasis (Sollinger, 2004) . Recently, mycophenolic acid was investigated against different types of coronavirus using a high-throughput screening approach, where the MPA showed potent anti-MHV-A59 activity in vitro at an EC 50 value of 0.17 µM compared to of HCoV-OC43, HCoV-NL63 and MERS-CoV (EC 50 values ranging from 0.18 to 1.95 µM). The value of CC 50 of MHV-A59 equals 4.18 µM that is greater than the values of HCoV-OC43, HCoV-NL63 and MERS-CoV ranging from 3.21 to 3.55 µM (Shen et al., 2019) . Another promising MPA derivative called mycophenolate mofetil (74) was reported to be an immunosuppressant, antineoplastic, and antiviral agent against HCoV-OC43, HCoV-NL63, MERS-CoV and SARS-CoV at EC 50 of 1.58, 0.23, 1.54 and 0.27 µM. The CC 50 of this compound ranged from 3.01 to 3.43 µM. The two compounds have similar chemical structures, but MPA showed a higher activity against MHV-A59 (EC 50 = 0.17 µM) (Shen et al., 2019) . Nowadays, there are 80 running and pending clinical trials in China in a serious attempt to find a potential treatment for COVID-19 (Maxmen, 2020) . In 2020, several compounds isolated from natural products (Figure 7 ; Table 3 ) were tested against coronavirus (COVID-19), i.e. Xiyanping (Mix of 78 and 79). Xiyanping, is a semisynthetic product derived from the active components of the Andrographis paniculata plant, and licensed in China as an anti-inflammatory agent (Chong et al., 2013; Xiao et al., 2013) . Xiyanping injection was investigated on 426 patients diagnosed with moderate to severe SARS-CoV-2 infection, every patient was injected with 10-20 ml of Xiyanping at 500 mg per 20 mL daily plus lopinavir/ritonavir tablets and α-interferon nebulization.

The stated drug (lopinavir/ritonavir) has the ability to inhibit protease and CYP3A metabolism thus showing antiviral properties (Driggin et al., 2020) (ClinicalTrials.gov;

Fingolimod (FTY720) (80), another compound derived from myriocin (ISP-1), is a metabolite of the Isaria sinclairii fungus. Fingolimod has been approved by the regulatory authorities of the US, EU, Australia, and Russia, to treat the relapsing remitting multiple sclerosis. Fingolimod consequently represents the primary oral drug for treatment of this central nervous autoimmune disease (Ingwersen et al., 2012) . In China, the Fingolimod drug was tested with 30 patients infected with COVID-19. Every patient was given 0.5 mg of Fingolimod orally daily, for three consecutive days. Commission for the treatment of inflammation in patients with COVID-19 (Cron and Chatham, 2020) . Previously, Tocilizumab (Actemra ® ) was permitted by means of the FDA as a drug used for inflammatory bowel disease treatment (Newman and Cragg, 2020). Recently, some physicians in Italy (Pascale Hospital, Naples) claimed that Actemra ® (Tocilizumab) succeeded in treating severely ill patients via blocking the inflammatory molecule interleukin-6, decreasing systemic inflammation, improving survival rate, adjusting hemodynamic and relieving the respiratory distress (Day, 2020) .

Severe Acute Respiratory Syndrome (SARS) and Severe Acute Respiratory Distress Syndrome (ARDS), the first one is an enzyme isolated from the Streptococci bacteria and the other is a glycosaminoglycan derived from dog liver (Anderson et al., 1948; McLean, 1959 ). The two compounds had been administrated in 40 patients infected with ARDS.

The first 20 patients were treated with heparin (10.000 IU) and the other 20 were treated with Streptokinase (250.000 IU). Each drug was prepared in a 3 ml volume of distilled water and nebulized for a period of 15 min every 4 h. The outcome of the study revealed an improvement of the hypoxemia as determined by PaO 2 /FiO 2 ratio >100, an improvement of the pulmonary compliance of the patient defined as dynamic compliance >50 ml/cm H 2 O, and a decrease of the occurrence of complications such as bleeding or coagulopathy within 72 h of initiation of therapy. Streptokinase and Heparin may prevent /or dissolve intra-alveolar fibrin clots respectively helping alveolar re-expansion (ClinicalTrials.gov; NCT03465085).

Methylprednisolone (81) is a natural products derivative (prednisolone derivative glucocorticoid) implemented by the FDA as an anticancer drug (Feinberg et al., 1957; Hall, 1992; Newman and Cragg, 2020; Ravina, 2011) . In early 2020, two clinical studies had been conducted on methylprednisolone against SARS-CoV-2 with 86 and 80 participants respectively. In both studies, all participants recovered except for one case that died in the first study (ClinicalTrials.gov; NCT04273321; NCT04244591). (Pillaiyar et al., 2020) . Nevertheless, many clinical studies were conducted on chloroquine as an anti-COVID-19 virus agent (ClinicalTrials.gov; NCT04303507), and its efficacy and safety remain unclear. It is proven highly effective in blocking viral replication in other infections including the SARS-associated coronavirus (CoV) (Cortegiani et al., 2020) . However, in a recent observational study, hydroxychloroquine treated patient was more seriously ill than those who hadn't received hydroxychloroquine (Geleris et al., 2020) .

As discussed earlier, small-molecule, approved drugs, and natural products are promising entities to combat COVID-19 depending on various mechanisms of action.

Traditional Chinese medicine (TCM) has a synergistic effect that plays a vital role in resisting the virus and resisting inflammation of the lung and thus some TCM formulas have been proposed and approved as patents against coronaviruses. Our review devotes to patents from natural product sources (Table 4 ).

One prescription for treating pneumonia caused by the new coronavirus infection was inspired by the TCM composition and discloses. The prescription raw materials combine, parts by weight, of the following TCM materials: 9 parts of Ephedra, 6 parts of honey-fried licorice root, 9 parts of almond, 15-30 parts of Gypsum, 9 parts of Cassia Twig, 9 parts of Rhizoma Alismatis, 9 parts of Frifola, 9 parts of bighead Atractylodes rhizome, 15 parts of Poria cocos, 16 parts of Radix Bupleuri, 6 parts of Scutellaria baicalensis, 9 parts of ginger processed Pinellia tuber, 9 parts of ginger, 9 parts of aster, 9 parts of Flos Farae, 9 parts of Blackberry lily, 6 parts of Asarum, 12 parts of Chinese yam, 6 parts of immature bitter orange, 6 parts of dried orange peel and 9 parts of 

The consumption of healthy diets is one way to boost the immune system and in return help in fighting off viruses (Galanakis, 2020) . There is a wide range of plants that contribute to boosting the immune system given their high content of a wide variety of nutrients and biological active compounds (Sultan et al., 2014) . A strong immune system is essential for fighting against COVID-19. COVID-19 seems to be hazardous for people with comorbidities and those have a weaker immune system than healthy ones (N. Chen et al., 2020; Jiang et al., 2020) . Garlic stimulates the immune system as it is rich with a wide plethora of nutrients, vitamins, and sulfur-containing compounds (Iciek et al., 2009) . Certain vegetables such as broccoli, spinach and sweet potatoes are abundant with vitamin A which include retinol, retinoic acid and β-carotene. These fat-soluble compounds participate in enhancement of the immune function. Additionally, isotretinoin (vitamin A derivative), inhibits ACE2 and the entry of SARS-COV-2 into the body thereby lower the susceptibility to infections (Galanakis, 2020) . Citrus fruits are one of the best sources for vitamin C. Vitamin C increases the production of white blood cells providing a key role in fighting infections (Calder et al., 2020) . Vitamins are recommended for the protection against coronavirus as they increase patients' resistance against infection (Basiri, 2020).

The outbreak of COVID-19 has swept across the world rapidly spreading in a very alarming pace invading more than 200 countries, territories, areas leaving a trail of victims behind. Although SARS-CoV-2 is accompanied by symptoms similar to that of SARS-CoV-2 i.e. fever, cough, and fatigue, SARS-CoV-2 is far more contagious. It can be transmitted by droplets or close contact. Given the affinity by which SARS-CoV-2 protein S can bind to ACE2 receptors, human to human transmission seems to spread much faster than the common flu or even the previous coronaviruses. Thus, containing the outbreak is a burning issue requires extensive measures and developing specific safe drugs. Natural products have so far proven to be promising for the development of effective and less toxic antiviral agents. Owing to the genetic resemblance between coronaviruses, the drugs and antiviral agents which are usually effective against the other types of coronaviruses could be used to treat COVID-19. Some of the reported antivirals showed a promising antiviral activity against at least four types of human coronaviruses with significant EC 50 and CC 50 values. Other therapeutic agents have also been reported and are already moving into clinical trials including Xiyanping, fingolimod, methylprednisolone, streptokinase, and heparin. Ou, X., Liu, Y., Lei, X., Li, P., Mi, D., Ren, L., Guo, L., Guo, R., Chen, T., Hu, J., Xiang, Z., Mu, Z., Chen, X., Chen, J., Hu, K., Jin, Q., Wang, J., Qian, Z., 2020.

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat. Commun. 11, 1-12.

Pan, Yaozong., Wang, Hengbin., Zhang, Dandan., Zhang, Bangguo., Li, Quan., Luo, Niancui., Cao, Zeqing., Zhai, Y., 2020 Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al., 2020 

Replication and morphogenesis of avian coronavirus in Vero cells and their inhibition by monensin

Quantitative antistreptokinase studies chemical drug therapeutics

Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa

Simultaneous determination of 9-dehydro-17-hydro-andrographolide and sodium 9-dehydro-17-hydro-andrographolide-19-yl sulfate in rat plasma by UHPLC-ESI-MS/MS after administration of xiyanping injection: application to a pharmacokinetic study

Glycyrrhizin, an active component of liquorice roots, and replication of SARSassociated coronavirus

Emergence of the Middle East respiratory syndrome coronavirus

Hosts and Sources of Endemic Human Coronaviruses

A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19

The Rheumatologist's Role in Covid-19

Glycyrrhiza glabra (Liquorice)-a potent medicinal herb

Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists

Serological survey of SARS-CoV-2 for experimental, domestic, companion and wild animals excludes intermediate hosts of 35 different species of animals

Inhibitory activities of baicalin against renin and angiotensin-converting enzyme

The Food Systems in the Era of the Coronavirus (COVID-19) Pandemic Crisis

From SARS to MERS: evidence and speculation

Prescription for treating pneumonia caused by novel coronavirus infection and application thereof

Minor alkaloids of Tylophora asthmatica: Revised structure of tylophorinidine

The neuroprotective pharmacology of methylprednisolone

Interferon-B and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays

Coronavirus Disease 2019 (COVID-19): What we know?

Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine

From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses

COVID-19 Spikehost cell receptor GRP78 binding site prediction

Biological properties of garlic and garlicderived organosulfur compounds

Fingolimod in multiple sclerosis: mechanisms of action and clinical efficacy

Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data

A hydroxychalcone derived from cinnamon functions as a mimetic for insulin in 3T3-L1 adipocytes

Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human

Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19)

History and recent advances in coronavirus discovery

Phytochemical analysis and antileukemic activity of polyphenolic constituents of Toona sinensis

A well infant with coronavirus disease 2019 (COVID-19) with high viral load

Incubation periods of acute respiratory viral infections: a systematic review

Mass masking in the COVID-19 epidemic: people need guidance

Anti-Cancer Effects of Pristimerin and the Mechanisms: A Critical Review

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

Identification of natural compounds with antiviral activities against SARS-associated coronavirus

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

Preparative isolation and purification of four compounds from Chinese medicinal herb Gentiana scabra Bunge by high-speed countercurrent chromatography

Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds

Antiviral natural products and herbal medicines

Hypothesis for potential pathogenesis of SARS-CoV-2 infection--a review of immune changes in patients with viral pneumonia

protease inhibitor isolated from the marine sponge Axinella cf. corrugata: structure elucidation and synthesis

Liquid chromatography-tandem mass spectrometry method for determination of N-acetylglucosamine concentration in human plasma

Phytochemical analysis and in vitro antiviral activities of the essential oils of seven Lebanon species

Structure and antimicrobial properties of monensin A and its derivatives: summary of the achievements

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs

Slew of trials launch to test coronavirus treatments in China

The discovery of heparin

Berbamine inhibits the growth of liver cancer cells and cancer-initiating cells by targeting Ca2+/calmodulinpreventing and treating viral diseases and application thereof

Asymptomatic cases in a family cluster with SARS-CoV-2 infection

Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors

Cassia tora Linn.: An overview

Coronavirus as a possible cause of severe acute respiratory syndrome

Recent discovery and development of inhibitors targeting coronaviruses

The evolution of drug discovery: from traditional medicines to modern drugs

Modulation of humoral and cell-mediated immune responses by Azadirachta indica (Neem) in mice

Counting on natural products for drug design

The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak

SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii

Novel Coronavirus (COVID-19) Outbreak: A Review of the Current Literature

Therapeutic basis of glycyrrhizin on chronic hepatitis B

High-throughput screening and identification of potent broad-spectrum inhibitors of coronaviruses

Clinical isolates of human coronavirus 229E bypass the endosome for cell entry

vitro antiviral activity of Echinaforce®, an Echinacea purpurea preparation, against common cold coronavirus 229E and highly pathogenic MERS-CoV and SARS-CoV. Virology

A Review of Coronavirus Disease-2019 (COVID-19)

Cycloheximide and other glutarimide antibiotics

World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19)

Mycophenolates in transplantation

Immunity: Plants as Effective Mediators

The pediatric burden of human coronaviruses evaluated for 20 years

Of chloroquine and COVID-19

Severe acute respiratory syndrome: clinical outcome and prognostic correlates

The Chemistry of Antimycin AX Structure of the Antimycins1

Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein

Clinical impact of human coronaviruses 229E and OC43 infection in diverse adult populations

Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing

Receptor recognition by the novel coronavirus from wuhan: an analysis based on decade-long structural studies of SARS coronavirus

Sachet for efficiently preventing novel coronavirus pneumonia and influenza

A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence

Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus

Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication

Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia

World Health Organization, 2020a. Coronavirus disease (COVID-19): Situation Report -176

Consensus document on the epidemiology of severe acute respiratory syndrome (SARS). World Health Organization

Traditional Chinese medicine formula for treating or preventing novel coronavirus pneumonia and viral influenza

Preparative isolation and purification of celastrol from Celastrus orbiculatus Thunb. by a new counter-current chromatography method with an upright coil planet centrifuge

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention

Epidemic prevention traditional Chinese medicine composition and preparation method and application thereof

Potential anti-angiogenic sulfates of andrographolide

Fumigation bath preparation for preventing and treating plague and use method and application thereof

Identification of phenanthroindolizines and phenanthroquinolizidines as novel potent anti-coronaviral agents for porcine enteropathogenic coronavirus transmissible gastroenteritis virus and human severe acute respiratory syndrome coronavirus

Oligomycins A and C, major secondary metabolites isolated from the newly isolated strain Streptomyces diastaticus

Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective

Zoonotic origins of human coronaviruses

Human aminopeptidase N is a receptor for human coronavirus 229E

Small Molecules Blocking the Entry of Severe Acute Respiratory Syndrome Coronavirus into Host Cells

Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains

Traditional Chinese medicine composition with function of resisting novel coronavirus sars-cov-2 and preparation method and application thereof

Zhang Tangjiang and Liang Honghai 30 parts of dried ginger, 30-60 parts of honey-fried licorice root, 15-30 parts of American ginseng, 10-30 parts of Ephedra, 15-30 parts of Cassia twig, 5-10 parts of Asarum, 10-70 parts of honeysuckle flower, 10-30 parts of Fructus Forsythiae, 10-30 parts of Isatis root, 10-30 parts of reed rhizome, 15-30 parts of Folium Isatidis, 20-240 parts of Gypsum, 10-30 parts of lalang grass rhizome, 10-15 parts of Rhizoma Paridis, 5-15 parts of wrinkled Gianthyssop herb

Chinese name: 陈文才 English name: Chen Wencai 20-100 g of Laggera pterodonta, 10-50 g of honeysuckle, 10-30 g of dried ginger, 10-40 g of divaricate saposhnikovia root, 10-50 g of Officinal magnolia bark and 10-60 g resisting virus and enhancing immunity

The authors declare no conflict of interest.

C. japonica L.Inhibits viral replication SARS-CoV 1.15 (127) µM (Wen et al., 2007) 8 β-hydroxyabieta-9(11),13-dien-12-one (N), diterpenoid ( 

Inhibits the enzymatic activity SARS-CoV 12.5-25(>100) µg/ml (Chen et al., 2004; Deng et al., 2012) Berbamine (N), bisbenzylisoquinoline alkaloids (19)

HCoV-OC431.48 (>20) µM (Meng et al., 2013; Shen et al., 2019 ) HCoV-NL63 9.46 (>20) µM MERS-CoV 13.14 (>20) µM MHV-A59 10.91 (>20) µM Beta-sitosterol (N), steroid (20)

Inhibits enzymatic activity of virus (Lin et al., 2005) Hinokinin (N), lignoidC. obtuse var. Inhibits viral replication SARS-CoV >10 (>750) µM (Wen et al., 2007) Indigo (N), alkaloid